Pub Date : 2026-03-01Epub Date: 2025-10-08DOI: 10.1002/hed.70057
Geena Jung, Ashley Stone, Shaynie Segal, Juan Lin, Bradley Schiff, Thomas Ow, Vikas Mehta, Richard V Smith
Background: This study elucidated sex disparities in head and neck squamous cell carcinoma (HNSCC) outcomes and investigated their interaction with race.
Methods: A total of 452 patients diagnosed with HNSCC were grouped by sex and race. Survival was analyzed using Kaplan-Meier curves with log rank tests and multivariable Cox models to assess sex/race associations while adjusting for confounders.
Results: Males were more likely to have advanced-stage cancer (79.6%, n = 257 vs. 70.5%, n = 91; p = 0.040). African American females had the best 5-year overall survival, followed by White females and Hispanic males. African American males had the worst survival (p = 0.0334). This sex disparity within the African American population persisted when controlling for confounding variables (HR = 0.343; 95% CI: 0.154-0.766; p = 0.0090) and was more pronounced in HPV-negative cases (HR = 0.184, 95% CI = 0.043-0.786).
Conclusions: Race-stratified analysis revealed a survival advantage for African American females over males. Further analysis shows that HPV status, alongside race, moderates the effect of sex on HNSCC outcomes.
Level of evidence: 3:
背景:本研究阐明了头颈部鳞状细胞癌(HNSCC)预后的性别差异,并调查了其与种族的相互作用。方法:将452例确诊为HNSCC的患者按性别和种族分组。生存率分析采用Kaplan-Meier曲线、对数秩检验和多变量Cox模型,在调整混杂因素的同时评估性别/种族之间的关联。结果:男性更容易患晚期癌症(79.6%,n = 257 vs. 70.5%, n = 91; p = 0.040)。非裔美国女性的5年总体生存率最高,其次是白人女性和西班牙裔男性。非裔美国男性的存活率最差(p = 0.0334)。在控制混杂变量后(HR = 0.343; 95% CI: 0.154-0.766; p = 0.0090),非裔美国人人群中的这种性别差异仍然存在,并且在hpv阴性病例中更为明显(HR = 0.184, 95% CI = 0.043-0.786)。结论:种族分层分析显示非裔美国女性比男性有生存优势。进一步的分析表明,HPV状态和种族一起,缓和了性别对HNSCC结果的影响。证据等级:3;
{"title":"Examining the Interaction Between Sex and Race in Outcomes of Head and Neck Squamous Cell Carcinoma.","authors":"Geena Jung, Ashley Stone, Shaynie Segal, Juan Lin, Bradley Schiff, Thomas Ow, Vikas Mehta, Richard V Smith","doi":"10.1002/hed.70057","DOIUrl":"10.1002/hed.70057","url":null,"abstract":"<p><strong>Background: </strong>This study elucidated sex disparities in head and neck squamous cell carcinoma (HNSCC) outcomes and investigated their interaction with race.</p><p><strong>Methods: </strong>A total of 452 patients diagnosed with HNSCC were grouped by sex and race. Survival was analyzed using Kaplan-Meier curves with log rank tests and multivariable Cox models to assess sex/race associations while adjusting for confounders.</p><p><strong>Results: </strong>Males were more likely to have advanced-stage cancer (79.6%, n = 257 vs. 70.5%, n = 91; p = 0.040). African American females had the best 5-year overall survival, followed by White females and Hispanic males. African American males had the worst survival (p = 0.0334). This sex disparity within the African American population persisted when controlling for confounding variables (HR = 0.343; 95% CI: 0.154-0.766; p = 0.0090) and was more pronounced in HPV-negative cases (HR = 0.184, 95% CI = 0.043-0.786).</p><p><strong>Conclusions: </strong>Race-stratified analysis revealed a survival advantage for African American females over males. Further analysis shows that HPV status, alongside race, moderates the effect of sex on HNSCC outcomes.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":"650-664"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-13DOI: 10.1002/hed.70064
Luca Calabrese, Monir Abousiam, Marta Tagliabue, Marco Ferrari, Rita De Berardinis, Gerardo Petruzzi, Francesco Mazzola, Alberto Grammatica, Davide Mattavelli, Remo Accorona, Alberto Vito Marcuzzo, Pierre Guarino, Francesco Mattioli, Alessia Rubini, Matteo Fermi, Andrea Sacchetto, Elisa Laura, Riccardo Nocini, Fabiola Incandela, Pietro De Luca, Andrea Iandelli, Filippo Marchi, Mario Turri Zanoni, Leone Giordano, Andrea Galli, Simone Mauramati, Virginia Corazzi, Chiara Bianchini, Mario Ciniglio Appiani, Matteo Garotta, Maria Silvia Lazio, Domenico Michele Modica, Salvatore Poma, Martina Renna, Annalisa Tosi, Melania Franco, Davide Di Santo, Giulia Togo, Paola Stritoni, Cecilia Albi, Ilaria Girolami, Enrico Fazio, Fabrizio Russo, Daniele Spada, Angela Gasparini, Virginia Dallari, Sara Bassani, Bianca Maria Festa, Dario Gregori, Carlotta Borghini, Gloria Brigiari, Francesca Angioletti, Alessandra Sordi, Milena Fior, Alessandra Ruaro, Valero Arietti, Giulia Gobbo, Francesco Uderzo, Rossana Bussani, Maurizio Pinamonti, Giuseppe Maruccio, Guglielmo Ronzani, Elisa Castelluccio, Pasquale d'Alessio, Daria Salsi, Roberto Di Carlo, Stefano Pelucchi, Giuseppe Bertolini, Massimo Ducci, Alberto Dragonetti, Mario Galfano, Franco Ionna, Doriano Politi, Roberto Saetti, Vincenzo Saita, Antonio Sarno, Giandomenico Maggiore, Angelo Camaioni, Luca De Campora, Luca Sacchetto, Paolo Castelnuovo, Marco Radici, Claudio Donadio Caporale, Domenico Cuda, Alberto Deganello, Andy Bertolin, Marco Benazzo, Giorgio Peretti, Mario Bussi, Daniele Marchioni, Livio Presutti, Giancarlo Tirelli, Mohssen Ansarin, Cesare Piazza, Piero Nicolai, Raul Pellini, Gabriele Molteni, Luca Gazzini
Background: Nodal metastases significantly affect prognosis in oral cavity squamous cell carcinoma (OCSCC). In early-stage OCSCC (cT1-T2 cN0), management of the clinically negative neck (cN0) remains controversial. Depth of invasion (DOI) is a key determinant for END, but other histopathological parameters, such as grading, perineural invasion (PNI), lymphovascular invasion (LVI), and worst pattern of invasion (WPOI), are emerging prognostic factors.
Methods: This multicenter retrospective study analyzed 1109 patients with cT1-T2 cN0 OCSCC treated at 30 Italian hospitals since 2017. Data on histopathological parameters, tumor characteristics, and patient outcomes were collected via the REDCap platform. Simple and multivariable logistic regression models were developed to assess predictors of occult nodal metastases.
Results: A total of 585 patients were clinically classified as cT1 tumors (53%), 503 as cT2 (45%), and cTis (1.9%). Of the 1109 patients, 193 (28%) had occult nodal metastases, with DOI, LVI, PNI, WPOI, and grading emerging as significant predictors. A predictive model integrating these variables demonstrated superior accuracy compared to a DOI-only model (AUROC comparison, p < 0.01).
Conclusion: This study highlights the importance of incorporating multiple histopathological parameters into risk models for occult nodal metastases, overcoming the fixed DOI as a cutoff. The proposed predictive model offers a more precise method for guiding END in early-stage OCSCC, allowing individualized risk estimation.
{"title":"When Should Elective Neck Dissection Be Considered for Early-Stage Oral Cavity Tumors? Insights From a Multicenter Study of 1109 Patients and Development of a Multiparametric Predictive Model.","authors":"Luca Calabrese, Monir Abousiam, Marta Tagliabue, Marco Ferrari, Rita De Berardinis, Gerardo Petruzzi, Francesco Mazzola, Alberto Grammatica, Davide Mattavelli, Remo Accorona, Alberto Vito Marcuzzo, Pierre Guarino, Francesco Mattioli, Alessia Rubini, Matteo Fermi, Andrea Sacchetto, Elisa Laura, Riccardo Nocini, Fabiola Incandela, Pietro De Luca, Andrea Iandelli, Filippo Marchi, Mario Turri Zanoni, Leone Giordano, Andrea Galli, Simone Mauramati, Virginia Corazzi, Chiara Bianchini, Mario Ciniglio Appiani, Matteo Garotta, Maria Silvia Lazio, Domenico Michele Modica, Salvatore Poma, Martina Renna, Annalisa Tosi, Melania Franco, Davide Di Santo, Giulia Togo, Paola Stritoni, Cecilia Albi, Ilaria Girolami, Enrico Fazio, Fabrizio Russo, Daniele Spada, Angela Gasparini, Virginia Dallari, Sara Bassani, Bianca Maria Festa, Dario Gregori, Carlotta Borghini, Gloria Brigiari, Francesca Angioletti, Alessandra Sordi, Milena Fior, Alessandra Ruaro, Valero Arietti, Giulia Gobbo, Francesco Uderzo, Rossana Bussani, Maurizio Pinamonti, Giuseppe Maruccio, Guglielmo Ronzani, Elisa Castelluccio, Pasquale d'Alessio, Daria Salsi, Roberto Di Carlo, Stefano Pelucchi, Giuseppe Bertolini, Massimo Ducci, Alberto Dragonetti, Mario Galfano, Franco Ionna, Doriano Politi, Roberto Saetti, Vincenzo Saita, Antonio Sarno, Giandomenico Maggiore, Angelo Camaioni, Luca De Campora, Luca Sacchetto, Paolo Castelnuovo, Marco Radici, Claudio Donadio Caporale, Domenico Cuda, Alberto Deganello, Andy Bertolin, Marco Benazzo, Giorgio Peretti, Mario Bussi, Daniele Marchioni, Livio Presutti, Giancarlo Tirelli, Mohssen Ansarin, Cesare Piazza, Piero Nicolai, Raul Pellini, Gabriele Molteni, Luca Gazzini","doi":"10.1002/hed.70064","DOIUrl":"10.1002/hed.70064","url":null,"abstract":"<p><strong>Background: </strong>Nodal metastases significantly affect prognosis in oral cavity squamous cell carcinoma (OCSCC). In early-stage OCSCC (cT1-T2 cN0), management of the clinically negative neck (cN0) remains controversial. Depth of invasion (DOI) is a key determinant for END, but other histopathological parameters, such as grading, perineural invasion (PNI), lymphovascular invasion (LVI), and worst pattern of invasion (WPOI), are emerging prognostic factors.</p><p><strong>Methods: </strong>This multicenter retrospective study analyzed 1109 patients with cT1-T2 cN0 OCSCC treated at 30 Italian hospitals since 2017. Data on histopathological parameters, tumor characteristics, and patient outcomes were collected via the REDCap platform. Simple and multivariable logistic regression models were developed to assess predictors of occult nodal metastases.</p><p><strong>Results: </strong>A total of 585 patients were clinically classified as cT1 tumors (53%), 503 as cT2 (45%), and cTis (1.9%). Of the 1109 patients, 193 (28%) had occult nodal metastases, with DOI, LVI, PNI, WPOI, and grading emerging as significant predictors. A predictive model integrating these variables demonstrated superior accuracy compared to a DOI-only model (AUROC comparison, p < 0.01).</p><p><strong>Conclusion: </strong>This study highlights the importance of incorporating multiple histopathological parameters into risk models for occult nodal metastases, overcoming the fixed DOI as a cutoff. The proposed predictive model offers a more precise method for guiding END in early-stage OCSCC, allowing individualized risk estimation.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":"708-721"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Dysphagia is common in patients with oral cancer undergoing flap reconstruction surgery. Surgical resection and reconstruction can affect the sensory and motor functions associated with swallowing. Studies on dysphagia have not investigated patients with oral cancer undergoing flap reconstruction surgery. In this hospital-based retrospective study, we examined the occurrence rates, risk factors, and clinical outcomes of dysphagia in patients with oral cancer undergoing flap reconstruction surgery.
Methods: Data were collected from the Chang Gung Research Database, which includes structured and unstructured electronic medical records. These data covered the period from January 1 to November 30, 2022. A total of 892 patients were included in the study. Dysphagia was identified on the basis of NANDA International Nursing Diagnoses criteria. Univariate and multivariable logistic regression models were used for data analysis.
Results: Of a total of 892 patients, 679 (76.1%) experienced dysphagia. Body mass index, smoking status, alcohol consumption, betel nut chewing, pain score, neck lymph node dissection, radiotherapy, and chemotherapy were identified as significant risk factors for dysphagia. Compared with those without dysphagia, patients with dysphagia had significantly higher rates of nasogastric tube placement and tracheostomy at discharge, longer hospital stays, and higher readmission rates.
Conclusions: Dysphagia is common in patients with oral cancer undergoing flap reconstruction surgery and is associated with certain risk factors and clinical outcomes. Enhancing postoperative care and implementing targeted interventions can facilitate the development of precise treatment plans aimed at reducing the incidence of dysphagia and improving the overall quality of care for patients undergoing flap reconstruction surgery.
{"title":"Occurrence, Risk Factors, and Early Clinical Outcomes of Dysphagia on Postoperative Day 7 in Patients With Oral Cancer Undergoing Free-Flap Reconstruction Surgery: A Hospital-Based Retrospective Study.","authors":"Wen-Chuan Hsu, Wen-Pin Yu, Hui-Mei Han, Huang-Kai Kao, Hsiao-Yean Chiu","doi":"10.1002/hed.70075","DOIUrl":"10.1002/hed.70075","url":null,"abstract":"<p><strong>Background: </strong>Dysphagia is common in patients with oral cancer undergoing flap reconstruction surgery. Surgical resection and reconstruction can affect the sensory and motor functions associated with swallowing. Studies on dysphagia have not investigated patients with oral cancer undergoing flap reconstruction surgery. In this hospital-based retrospective study, we examined the occurrence rates, risk factors, and clinical outcomes of dysphagia in patients with oral cancer undergoing flap reconstruction surgery.</p><p><strong>Methods: </strong>Data were collected from the Chang Gung Research Database, which includes structured and unstructured electronic medical records. These data covered the period from January 1 to November 30, 2022. A total of 892 patients were included in the study. Dysphagia was identified on the basis of NANDA International Nursing Diagnoses criteria. Univariate and multivariable logistic regression models were used for data analysis.</p><p><strong>Results: </strong>Of a total of 892 patients, 679 (76.1%) experienced dysphagia. Body mass index, smoking status, alcohol consumption, betel nut chewing, pain score, neck lymph node dissection, radiotherapy, and chemotherapy were identified as significant risk factors for dysphagia. Compared with those without dysphagia, patients with dysphagia had significantly higher rates of nasogastric tube placement and tracheostomy at discharge, longer hospital stays, and higher readmission rates.</p><p><strong>Conclusions: </strong>Dysphagia is common in patients with oral cancer undergoing flap reconstruction surgery and is associated with certain risk factors and clinical outcomes. Enhancing postoperative care and implementing targeted interventions can facilitate the development of precise treatment plans aimed at reducing the incidence of dysphagia and improving the overall quality of care for patients undergoing flap reconstruction surgery.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":"813-820"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-25DOI: 10.1002/hed.70089
Cameron C Lee, Sahil Gandotra, Aaron Bliss, Glyndwr W Jenkins, Donita Dyalram, Kyle Hatten, Kelly Moyer, Ranee Mehra, Jason Molitoris, Matthew Ferris, Rodney Taylor, Jeffrey S Wolf, Joshua E Lubek
Background: Persistent opioid use after head and neck cancer surgery is a growing concern, but data regarding incidence and risk factors remain limited.
Methods: This retrospective cohort study included patients who underwent primary resection of oral cavity squamous cell carcinoma between 2016 and 2022. Preoperative opioid use was classified as naïve, intermittent, or chronic using prescription drug monitoring data. Persistent use was defined as filling an opioid prescription attributed to surgery and two consecutive prescriptions between 120 and 365 days postoperatively. Regression analysis identified independent predictors.
Results: Among 430 subjects, 18.8% met criteria for persistent opioid use. Chronic preoperative use (p = 0.008), G-tube persistence at 12 months (p = 0.041), chronic pain diagnosis (p = 0.036), and cancer recurrence (p = 0.021) were independent predictors. Persistent use peaked between 120 and 180 days postoperatively.
Conclusion: Persistent opioid use is common after oral cancer resection and is strongly associated with preoperative opioid use. Early risk stratification may improve outcomes.
{"title":"Persistent Opioid Use Following Resection of Oral Cavity Squamous Cell Carcinoma: Incidence and Risk Factors.","authors":"Cameron C Lee, Sahil Gandotra, Aaron Bliss, Glyndwr W Jenkins, Donita Dyalram, Kyle Hatten, Kelly Moyer, Ranee Mehra, Jason Molitoris, Matthew Ferris, Rodney Taylor, Jeffrey S Wolf, Joshua E Lubek","doi":"10.1002/hed.70089","DOIUrl":"10.1002/hed.70089","url":null,"abstract":"<p><strong>Background: </strong>Persistent opioid use after head and neck cancer surgery is a growing concern, but data regarding incidence and risk factors remain limited.</p><p><strong>Methods: </strong>This retrospective cohort study included patients who underwent primary resection of oral cavity squamous cell carcinoma between 2016 and 2022. Preoperative opioid use was classified as naïve, intermittent, or chronic using prescription drug monitoring data. Persistent use was defined as filling an opioid prescription attributed to surgery and two consecutive prescriptions between 120 and 365 days postoperatively. Regression analysis identified independent predictors.</p><p><strong>Results: </strong>Among 430 subjects, 18.8% met criteria for persistent opioid use. Chronic preoperative use (p = 0.008), G-tube persistence at 12 months (p = 0.041), chronic pain diagnosis (p = 0.036), and cancer recurrence (p = 0.021) were independent predictors. Persistent use peaked between 120 and 180 days postoperatively.</p><p><strong>Conclusion: </strong>Persistent opioid use is common after oral cancer resection and is strongly associated with preoperative opioid use. Early risk stratification may improve outcomes.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":"843-855"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145369196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-17DOI: 10.1002/hed.70074
Brianna Brammer, Brendan L C Kinney, Vikash Kansal, Nicole C Schmitt
Background: Recurrence of head and neck squamous cell carcinoma (HNSCC) affects nearly half of patients and greatly reduces survival. There are currently no well-established mechanisms to predict which HNSCC patients will experience disease recurrence. We have previously shown that an elevated proportion of highly differentiated, CD57+ effector memory T (HD TEMRA) cells in circulation is associated with early recurrence and poor locoregional disease control in HNSCC patients.
Methods: Here, we present refined flow cytometry panels utilizing fewer fluorescent antibodies that retain the prognostic value of HD TEMRA cells in predicting HNSCC recurrence.
Results: In our cohort of surgically treated HNSCC patients, identifying HD TEMRA cells via flow cytometry as live CD8+ CD28- CD57+ cells effectively predicted disease recurrence. When assessing this cohort by disease subsite, we found that for patients with oral squamous cell carcinoma, identifying HD TEMRA cells by CD8+ CD57+ alone was sufficient for predicting locoregional disease recurrence.
Conclusions: These refined panels enhance the clinical utility of HD TEMRA proportion as a biomarker due to their technical and analytic ease. Implementation of HD TEMRA cell proportion as a clinical biomarker could aid in personalized HNSCC treatment planning.
{"title":"A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck Cancer.","authors":"Brianna Brammer, Brendan L C Kinney, Vikash Kansal, Nicole C Schmitt","doi":"10.1002/hed.70074","DOIUrl":"10.1002/hed.70074","url":null,"abstract":"<p><strong>Background: </strong>Recurrence of head and neck squamous cell carcinoma (HNSCC) affects nearly half of patients and greatly reduces survival. There are currently no well-established mechanisms to predict which HNSCC patients will experience disease recurrence. We have previously shown that an elevated proportion of highly differentiated, CD57+ effector memory T (HD TEMRA) cells in circulation is associated with early recurrence and poor locoregional disease control in HNSCC patients.</p><p><strong>Methods: </strong>Here, we present refined flow cytometry panels utilizing fewer fluorescent antibodies that retain the prognostic value of HD TEMRA cells in predicting HNSCC recurrence.</p><p><strong>Results: </strong>In our cohort of surgically treated HNSCC patients, identifying HD TEMRA cells via flow cytometry as live CD8+ CD28- CD57+ cells effectively predicted disease recurrence. When assessing this cohort by disease subsite, we found that for patients with oral squamous cell carcinoma, identifying HD TEMRA cells by CD8+ CD57+ alone was sufficient for predicting locoregional disease recurrence.</p><p><strong>Conclusions: </strong>These refined panels enhance the clinical utility of HD TEMRA proportion as a biomarker due to their technical and analytic ease. Implementation of HD TEMRA cell proportion as a clinical biomarker could aid in personalized HNSCC treatment planning.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":"758-764"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145314234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dan M Fliss, Omer J Ungar, Helena Levyn, Cristina Valero, Dauren Adilbay, Alana Eagan, Junting Zheng, Mithat Gonen, Marc A Cohen, Snehal Patel, Ian Ganly, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Benedict J Panizza, James Bowman, Catherine Barnett, Luiz P Kowalski, Ronaldo N Toledo, John DeAlmeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard Harvey, C Rene Leemans, Jan-Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Claudio Cernea, Sergio Goncalves, Rodney Schlosser, Fernando Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y Su, Shaan M Raza, Franco DeMonte, Ehab Hanna, Jatin P Shah
Background: The current study presents the efforts of a global collaborative group to review the management and outcomes of malignant tumors of the skull base in the pediatric population worldwide.
Patients and methods: A total of 28 institutions contributed data on 3061 patients. From this, there were 64 pediatric patients (2.1%). Clinical variables, overall and disease-free survival (OS and DFS) outcomes, and multivariable factors associated with outcome were evaluated.
Results: The male-to-female ratio was 37:27 and the median [IQR] age at diagnosis was 14.0 [9.6-16.0] years. The most common malignancy was sarcoma (57.8%), followed by esthesioneuroblastoma (25.0%) and carcinoma (17.2%). Negative margins were achieved in 53.1% children. Dural invasion was associated with reduced OS and DFS. Adjuvant radiotherapy was associated with improved survival outcomes.
Conclusions: Open approaches were widely used for pediatric skull base tumor resection in the period between 1995 and 2015 but we saw a rise in the use of endoscopic and combined techniques by the end of the period covered by this study. Our results may represent a transitional era in which alternative endoscopic techniques continue to expand.
{"title":"Skull Base Surgery in the Pediatric Population-The 2nd International Collaborative Study (1995-2015).","authors":"Dan M Fliss, Omer J Ungar, Helena Levyn, Cristina Valero, Dauren Adilbay, Alana Eagan, Junting Zheng, Mithat Gonen, Marc A Cohen, Snehal Patel, Ian Ganly, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Benedict J Panizza, James Bowman, Catherine Barnett, Luiz P Kowalski, Ronaldo N Toledo, John DeAlmeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard Harvey, C Rene Leemans, Jan-Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Claudio Cernea, Sergio Goncalves, Rodney Schlosser, Fernando Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y Su, Shaan M Raza, Franco DeMonte, Ehab Hanna, Jatin P Shah","doi":"10.1002/hed.70168","DOIUrl":"https://doi.org/10.1002/hed.70168","url":null,"abstract":"<p><strong>Background: </strong>The current study presents the efforts of a global collaborative group to review the management and outcomes of malignant tumors of the skull base in the pediatric population worldwide.</p><p><strong>Patients and methods: </strong>A total of 28 institutions contributed data on 3061 patients. From this, there were 64 pediatric patients (2.1%). Clinical variables, overall and disease-free survival (OS and DFS) outcomes, and multivariable factors associated with outcome were evaluated.</p><p><strong>Results: </strong>The male-to-female ratio was 37:27 and the median [IQR] age at diagnosis was 14.0 [9.6-16.0] years. The most common malignancy was sarcoma (57.8%), followed by esthesioneuroblastoma (25.0%) and carcinoma (17.2%). Negative margins were achieved in 53.1% children. Dural invasion was associated with reduced OS and DFS. Adjuvant radiotherapy was associated with improved survival outcomes.</p><p><strong>Conclusions: </strong>Open approaches were widely used for pediatric skull base tumor resection in the period between 1995 and 2015 but we saw a rise in the use of endoscopic and combined techniques by the end of the period covered by this study. Our results may represent a transitional era in which alternative endoscopic techniques continue to expand.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146159279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Khanh Linh Tran, Zora Heer, Harkaran Singh Dial, Cornelius Kürten, Brian Ma, Alex Chen, Natalie Mezey, Masih Sarafan, Sidney S Fels, Antony J Hodgson, Farahna Sabiq, J Scott Durham, Eitan Prisman
Background: Bony nonunion is an important complication in head and neck reconstruction, but its definition, incidence, and treatment are not well-reported.
Methods: MEDLINE, Embase, CENTRAL, and Web of Science were searched from October 1st, 1990 to January 6th, 2025 for studies reporting bony union for maxilla or mandible reconstruction with vascularized free flap.
Results: The search strategy yielded 5985 abstracts and 52 were included in the review. Definitions of bony nonunion varied and were reported in 20 studies. Higher pooled rates of complete union were observed in reconstructions of the maxilla, reconstructions using the radius, and surgeries aided by virtual surgical planning. Treatment for nonunion was reported in 11 studies.
Conclusions: Virtual surgical planning has the potential to improve union outcomes and reduce the need for revision surgeries in nonunion cases. The heterogeneity of the studies necessitates randomized controlled trials for further analysis of the nonunion risk factors and consequences.
背景:骨不连是头颈部重建术中一种重要的并发症,但其定义、发生率和治疗方法尚未见报道。方法:检索1990年10月1日至2025年1月6日,MEDLINE、Embase、CENTRAL和Web of Science中有关血管带瓣上颌或下颌骨重建骨愈合的研究。结果:检索策略共获得5985篇摘要,其中52篇被纳入综述。骨不连的定义各不相同,在20项研究中报道。在上颌骨重建、桡骨重建和虚拟手术计划辅助下的手术中,观察到更高的完全愈合率。11项研究报道了骨不连的治疗方法。结论:虚拟手术计划有可能改善愈合结果,减少不愈合病例的翻修手术需求。研究的异质性需要随机对照试验来进一步分析骨不连的危险因素和后果。
{"title":"Bony Union in Maxilla and Mandible Free Flap Reconstruction: A Systematic Review and Meta-Analysis.","authors":"Khanh Linh Tran, Zora Heer, Harkaran Singh Dial, Cornelius Kürten, Brian Ma, Alex Chen, Natalie Mezey, Masih Sarafan, Sidney S Fels, Antony J Hodgson, Farahna Sabiq, J Scott Durham, Eitan Prisman","doi":"10.1002/hed.70153","DOIUrl":"https://doi.org/10.1002/hed.70153","url":null,"abstract":"<p><strong>Background: </strong>Bony nonunion is an important complication in head and neck reconstruction, but its definition, incidence, and treatment are not well-reported.</p><p><strong>Methods: </strong>MEDLINE, Embase, CENTRAL, and Web of Science were searched from October 1st, 1990 to January 6th, 2025 for studies reporting bony union for maxilla or mandible reconstruction with vascularized free flap.</p><p><strong>Results: </strong>The search strategy yielded 5985 abstracts and 52 were included in the review. Definitions of bony nonunion varied and were reported in 20 studies. Higher pooled rates of complete union were observed in reconstructions of the maxilla, reconstructions using the radius, and surgeries aided by virtual surgical planning. Treatment for nonunion was reported in 11 studies.</p><p><strong>Conclusions: </strong>Virtual surgical planning has the potential to improve union outcomes and reduce the need for revision surgeries in nonunion cases. The heterogeneity of the studies necessitates randomized controlled trials for further analysis of the nonunion risk factors and consequences.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146159230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Fibrous dysplasia (FD) is a rare osseous disorder with limited understanding. This study aimed to evaluate the clinical characteristics of craniofacial FD (CFD) and orbital FD (OFD), explore vision impairment mechanisms, and identify recurrence risk factors.
Methods: A retrospective analysis was conducted on 54 CFD patients across three centers, including 30 patients with orbit involved.
Results: OFD patients exhibited higher prevalences of polyostotic FD and McCune-Albright syndrome, and more often underwent debulking rather than radical surgery. Vision impairment was primarily attributed to compressive and stretched optic neuropathy. Polyostotic involvement (p = 0.034) was a risk factor of subjective recurrence. Surgery age < 16 years (p = 0.046) and abnormal body mass index (p = 0.002) were associated with greater postoperative lesion regrowth volume.
Conclusions: OFD patients exhibit distinct clinical features. Optic canal decompression is not required for all OFD-related vision loss patients. Recurrence risk should be thoroughly assessed before surgery.
{"title":"Optimizing Surgical Management of Craniofacial and Orbital Fibrous Dysplasia: A Multi-Center Retrospective Study.","authors":"Lianfei Fang, Yinwei Li, Yining Wei, Haiyang Zhang, Ming Lin, Chao Shen, Surui Sheng, Yue He, Zhifeng Shi, Huifang Zhou","doi":"10.1002/hed.70190","DOIUrl":"https://doi.org/10.1002/hed.70190","url":null,"abstract":"<p><strong>Background: </strong>Fibrous dysplasia (FD) is a rare osseous disorder with limited understanding. This study aimed to evaluate the clinical characteristics of craniofacial FD (CFD) and orbital FD (OFD), explore vision impairment mechanisms, and identify recurrence risk factors.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 54 CFD patients across three centers, including 30 patients with orbit involved.</p><p><strong>Results: </strong>OFD patients exhibited higher prevalences of polyostotic FD and McCune-Albright syndrome, and more often underwent debulking rather than radical surgery. Vision impairment was primarily attributed to compressive and stretched optic neuropathy. Polyostotic involvement (p = 0.034) was a risk factor of subjective recurrence. Surgery age < 16 years (p = 0.046) and abnormal body mass index (p = 0.002) were associated with greater postoperative lesion regrowth volume.</p><p><strong>Conclusions: </strong>OFD patients exhibit distinct clinical features. Optic canal decompression is not required for all OFD-related vision loss patients. Recurrence risk should be thoroughly assessed before surgery.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146159266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David J Fei-Zhang, Helena Kim, Daniel C Chelius, Anthony M Sheyn, Jeffrey C Rastatter, Jill N D'Souza
Background: Nutrition and socioeconomic status are well-established risk factors for oropharyngeal squamous cell carcinoma (OPSCC) progression and mortality, but the impact of the food environment remains largely understudied.
Methods: In this retrospective study, race/ethnicity-stratified inferential and mediation analyses assessed selected clinical outcomes for 70 581 OPSCC patients from the Surveillance, Epidemiology, and End Results. We examined the effects of Food Environment Atlas scores composited from 282-county-level variables, adjusted for the effects of traditional social determinants of health.
Results: Worse food environments were modestly associated with increased risk of overall mortality (aHR-1.03, 95% CI, 1.02-1.04), 3-year overall mortality (aOR-1.04, 95% CI, 1.03-1.05), and advanced stage at diagnosis (aOR-1.02, 95% CI, 1.01-1.03) in the whole sample, with exacerbated associations across all outcomes among non-White patients. The food environment was not significantly associated with having more than one primary tumor at diagnosis. Traditional social determinants of health partially mediated mortality, but not staging effects.
Conclusions: Poor food environments were modestly associated with increased OPSCC mortality and advanced staging, with exacerbated effects in non-White patients. These retrospective findings support investigations into specific mechanisms of food environment inequity on OPSCC outcomes to guide targeted public health interventions such as subsidized transportation.
{"title":"The Impact of Food Environment on Oropharyngeal Cancer Prognosis in the United States.","authors":"David J Fei-Zhang, Helena Kim, Daniel C Chelius, Anthony M Sheyn, Jeffrey C Rastatter, Jill N D'Souza","doi":"10.1002/hed.70195","DOIUrl":"https://doi.org/10.1002/hed.70195","url":null,"abstract":"<p><strong>Background: </strong>Nutrition and socioeconomic status are well-established risk factors for oropharyngeal squamous cell carcinoma (OPSCC) progression and mortality, but the impact of the food environment remains largely understudied.</p><p><strong>Methods: </strong>In this retrospective study, race/ethnicity-stratified inferential and mediation analyses assessed selected clinical outcomes for 70 581 OPSCC patients from the Surveillance, Epidemiology, and End Results. We examined the effects of Food Environment Atlas scores composited from 282-county-level variables, adjusted for the effects of traditional social determinants of health.</p><p><strong>Results: </strong>Worse food environments were modestly associated with increased risk of overall mortality (aHR-1.03, 95% CI, 1.02-1.04), 3-year overall mortality (aOR-1.04, 95% CI, 1.03-1.05), and advanced stage at diagnosis (aOR-1.02, 95% CI, 1.01-1.03) in the whole sample, with exacerbated associations across all outcomes among non-White patients. The food environment was not significantly associated with having more than one primary tumor at diagnosis. Traditional social determinants of health partially mediated mortality, but not staging effects.</p><p><strong>Conclusions: </strong>Poor food environments were modestly associated with increased OPSCC mortality and advanced staging, with exacerbated effects in non-White patients. These retrospective findings support investigations into specific mechanisms of food environment inequity on OPSCC outcomes to guide targeted public health interventions such as subsidized transportation.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shawn Joseph Thadathil, Karunya Gopal Rajagopal, Iona Leekha Mathew, Mihir Mohan, Sarah Mary Thampi, Sourabh Padmanabhan, Abhijith George
Background: The global incidence of thyroid cancer has risen over recent decades, largely attributed to increased detection of thyroid nodules. This trend has raised concerns regarding overdiagnosis and overtreatment. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) plays a pivotal role in preoperative risk stratification, yet clinical decision-making remains challenging in indeterminate categories (Bethesda III-V), particularly in resource-limited settings where molecular testing is unavailable.
Objective: To determine the risk of malignancy (ROM) for each TBSRTC category among patients who underwent thyroid surgery over a 10-year period at a tertiary care center in India, and to compare these rates with the 2023 TBSRTC risk estimates.
Methods: This retrospective study analyzed fine-needle aspiration cytology and histopathology data for all patients who underwent thyroid surgeries conducted between 2014 and 2024. ROM across TBSRTC categories was calculated and compared with established TBSRTC risk estimates.
Results: A 100% malignancy rate was observed in TBSRTC VI category, supporting the reliability of surgical decisions in this group. However, significantly higher malignancy rates were found in TBSRTC categories III (58.7%), IV (82.7%), and V (100%) compared to TBSRTC estimates (22%, 30%, and 74%, respectively). TBSRTC III nuclear had a significantly higher malignancy rate (70.0%) than TBSRTC III other (40.57%).
Conclusion: Institution specific malignancy data enhances the clinical utility of TBSRTC and improves patient counseling, particularly in settings where molecular diagnostics are not feasible.
{"title":"Are We Operating Smarter? Risk of Malignancy Across Bethesda Categories-A 10-Year Institutional Experience.","authors":"Shawn Joseph Thadathil, Karunya Gopal Rajagopal, Iona Leekha Mathew, Mihir Mohan, Sarah Mary Thampi, Sourabh Padmanabhan, Abhijith George","doi":"10.1002/hed.70191","DOIUrl":"https://doi.org/10.1002/hed.70191","url":null,"abstract":"<p><strong>Background: </strong>The global incidence of thyroid cancer has risen over recent decades, largely attributed to increased detection of thyroid nodules. This trend has raised concerns regarding overdiagnosis and overtreatment. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) plays a pivotal role in preoperative risk stratification, yet clinical decision-making remains challenging in indeterminate categories (Bethesda III-V), particularly in resource-limited settings where molecular testing is unavailable.</p><p><strong>Objective: </strong>To determine the risk of malignancy (ROM) for each TBSRTC category among patients who underwent thyroid surgery over a 10-year period at a tertiary care center in India, and to compare these rates with the 2023 TBSRTC risk estimates.</p><p><strong>Methods: </strong>This retrospective study analyzed fine-needle aspiration cytology and histopathology data for all patients who underwent thyroid surgeries conducted between 2014 and 2024. ROM across TBSRTC categories was calculated and compared with established TBSRTC risk estimates.</p><p><strong>Results: </strong>A 100% malignancy rate was observed in TBSRTC VI category, supporting the reliability of surgical decisions in this group. However, significantly higher malignancy rates were found in TBSRTC categories III (58.7%), IV (82.7%), and V (100%) compared to TBSRTC estimates (22%, 30%, and 74%, respectively). TBSRTC III nuclear had a significantly higher malignancy rate (70.0%) than TBSRTC III other (40.57%).</p><p><strong>Conclusion: </strong>Institution specific malignancy data enhances the clinical utility of TBSRTC and improves patient counseling, particularly in settings where molecular diagnostics are not feasible.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}